| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.86▼ | 0.86▼ | 0.86▼ | 0.82▼ | 0.82▼ |
| MA10 | 0.88▼ | 0.88▼ | 0.89▼ | 0.82▼ | 0.80▼ |
| MA20 | 0.89▼ | 0.88▼ | 0.87▼ | 0.84▼ | 0.80▼ |
| MA50 | 0.91▼ | 0.85▼ | 0.84▼ | 0.81▼ | 0.88▼ |
| MA100 | 0.87▼ | 0.90▼ | 0.96▼ | 0.83▼ | 1.10▼ |
| MA200 | 1.02▼ | 1.10▼ | 1.02▼ | 0.90▼ | 6.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.009▼ | -0.005▼ | -0.009▼ | 0.007▲ |
| RSI | 35.013▼ | 44.239▼ | 46.529▼ | 39.705▼ | 43.871▼ |
| STOCH | 20.665 | 10.560▼ | 12.898▼ | 26.509 | 35.662 |
| WILL %R | -100.000▼ | -100.000▼ | -94.542▼ | -86.364▼ | -86.364▼ |
| CCI | -151.240▼ | -129.193▼ | -57.198 | -227.957▼ | 95.082 |
|
Tuesday, November 12, 2019 04:00 AM
SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced positive topline results from the Ovaprene postcoital test (PCT ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/19 | 0.77 | 0.78 | 0.69 | 0.75 | 509,800 |
| 13/11/19 | 0.818 | 0.82 | 0.751 | 0.785 | 456,100 |
| 12/11/19 | 0.898 | 0.92 | 0.821 | 0.83 | 884,500 |
| 11/11/19 | 1.00 | 1.13 | 0.86 | 0.898 | 7,953,700 |
| 08/11/19 | 0.807 | 0.859 | 0.803 | 0.831 | 41,100 |
| 07/11/19 | 0.87 | 0.87 | 0.81 | 0.825 | 40,900 |
| 06/11/19 | 0.838 | 0.87 | 0.82 | 0.847 | 27,200 |
| 05/11/19 | 0.8378 | 0.8441 | 0.82 | 0.8288 | 24,799 |
| 04/11/19 | 0.805 | 0.86 | 0.805 | 0.83 | 59,641 |
| 01/11/19 | 0.84 | 0.84 | 0.80 | 0.81 | 18,300 |
|
|
||||
|
|
||||
|
|